INOVIO PHARMACEUTICALS, INC. - Common Stock (INO)

Historical Holders from Q4 2023 to Q3 2025

Symbol
INO on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
66,729,680
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
20,711,886
Holdings value
$48,449,935
% of all portfolios
0%
Number of holders
98
Number of buys
46
Number of sells
54
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% $19,200,995 9,846,664 FMR LLC 28 Nov 2025
JANUS HENDERSON GROUP PLC 10% +63% $12,999,275 +$6,630,068 6,666,295 +104% JANUS HENDERSON GROUP PLC 28 Nov 2025
Adage Capital Management, L.P. 10% $12,911,301 5,517,650 Adage Capital Management, L.P. 30 Sep 2025
Alyeska Investment Group, L.P. 7.5% $9,360,000 4,000,000 Alyeska Investment Group, L.P. 30 Sep 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 9.2% $6,794,333 3,633,333 Highbridge Capital Management, LLC 31 Dec 2024
VANGUARD GROUP INC 5.5% +18% $3,794,153 +$664,546 2,028,959 +21% The Vanguard Group 31 Mar 2025
Stonepine Capital Management, LLC 3.8% -28% $2,683,444 -$900,721 1,434,997 -25% Stonepine Capital Management, LLC 31 Mar 2025
Deep Track Capital, LP 2.4% $3,076,623 1,314,796 Deep Track Capital, LP 30 Sep 2025
BlackRock, Inc. 1.5% -80% $1,099,608 -$3,642,379 537,627 -77% BlackRock, Inc. 30 Jun 2025
As of 30 Sep 2025 INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 20,711,886 shares of 66,729,680 outstanding shares and own 31% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) own 30% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.1% $8,022,856 3,428,571
JANUS HENDERSON GROUP PLC 4.9% $7,626,717 3,266,260
VANGUARD GROUP INC 4.1% $6,348,120 2,712,872 +35%
Boxer Capital Management, LLC 3.4% $5,382,000 2,300,000
MILLENNIUM MANAGEMENT LLC 3% $4,615,692 1,972,518 +469%
RENAISSANCE TECHNOLOGIES LLC 1.2% $1,910,233 816,339 +149%
D. E. Shaw & Co., Inc. 1.2% $1,887,776 806,742
MORGAN STANLEY 1.2% $1,841,053 786,774 +96%
BANK OF AMERICA CORP /DE/ 0.95% $1,488,383 636,061 -50%
GEODE CAPITAL MANAGEMENT, LLC 0.82% $1,279,649 546,747 +25%
BlackRock, Inc. 0.75% $1,168,603 499,403 -7.1%
GSA CAPITAL PARTNERS LLP 0.66% $1,037,000 443,104 +171%
UBS Group AG 0.44% $685,765 293,062 +47%
TWO SIGMA INVESTMENTS, LP 0.44% $680,472 290,800 +300%
NORTHERN TRUST CORP 0.36% $558,022 238,471 -6.3%
XTX Topco Ltd 0.32% $492,727 210,567 +855%
STATE STREET CORP 0.28% $435,731 186,210 +51%
ROYAL BANK OF CANADA 0.25% $387,000 165,408 +35%
GMT CAPITAL CORP 0.19% $295,118 126,119 0%
Headlands Technologies LLC 0.16% $257,559 110,068 +32464%
TWO SIGMA ADVISERS, LP 0.16% $254,360 108,701
JPMORGAN CHASE & CO 0.1% $152,583 65,206 +1667%
HRT FINANCIAL LP 0.1% $152,000 65,065 -9.9%
Concurrent Investment Advisors, LLC 0.08% $131,066 56,011 0%
GOLDMAN SACHS GROUP INC 0.08% $125,683 53,711 -61%

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 20,711,886 $48,449,935 +$25,433,676 $2.34 98
2025 Q2 10,168,502 $20,694,831 -$6,577,397 $2.04 101
2025 Q1 13,600,161 $22,159,691 +$51,992 $1.63 105
2024 Q4 13,346,624 $24,424,740 +$7,463,553 $1.83 100
2024 Q3 8,566,045 $49,511,575 +$2,096,827 $5.78 95
2024 Q2 8,056,972 $65,100,837 +$29,640,224 $8.08 92
2024 Q1 4,044,287 $56,123,192 +$53,680,856 $13.88 83
2023 Q4 298,900 $152,940 +$152,930 $0.5100 7